LSI USA

https://lnkd.in/gkSugvXh

Continuing our ABCs of LSI USA ‘25 — today we’re featuring the emerging Medtech and Healthtech companies who presented on stage that start with the letter S. Here’s Part 2: • Sonic Incytes Medical Corp. — Barry Allen • Sonion Health — Jim Fidacaro • Sonescence, Inc./Sonopor, Inc./Sonofii, Inc. — Roberta Lee • Soterya, Inc. — Norman Wen • Sparta Biomedical — Dimitrios Angelis, JD • Spatial Surgical — Skye Priestley • SpectraWAVE, Inc. — Eman Namati • SpinePoint — Lali Sekhon, MD PhD MBA • Spiro Robotics — Dimitri Sokolov • STENTiT — Bart Sanders • STIMIT AG — Ronja Müller-Bruhn-Bruhn • SurgiBox Inc. — Mike Teodorescu • Sutra Medical, Inc. — Wei Sun • SyMap Medical — Jie Wang • Synergia Medical — Charles Nolet • Synova Life Sciences — John Chi 季崇健 Tune in each day as we recap LSI USA ‘25 from A to Z. PS: Registration is now open for LSI USA ‘26 next March 16-20 in Dana Point, California. Secure your spot early to take advantage of our best rates and have first priority for our hotel room block.

Cypher Medical has developed a novel technology for visualizing red blood cell sedimentation. By integrating this technology into a waste container, it automatically separates red blood cells from other fluids, providing a fast and efficient method for identifying red blood cell sedimentation during surgery or childbirth. This patented solution can be applied to various biological fluid collection products. Cypher Medical is based in Texas and has partnered with an internationally recognized tech-development organization to advance its product development. Want to learn more about Cypher Medical? Catch Chris Carew’s full video presentation from LSI USA ‘25 on our website and YouTube channel. PS: Registration is now open for LSI USA ‘26 next March 16-20 in Dana Point, California. Secure your spot early to take advantage of our best rates and have first priority for our hotel room block.

We’re grateful to LSI USA for the opportunity to present on Peytant Solutions, Inc.'s innovative technology to the investment community. A special thank you to our CEO, John Schorgl, for sharing our vision and innovation on stage. We were proud to represent our team’s passion, progress, and commitment to advancing care at this important investor-related event. https://lnkd.in/gTjwsbNb #Peytant #LSI #MedicalTechnology LSI

Continuing our ABCs of LSI USA ‘25 — today we’re featuring the emerging Medtech and Healthtech companies who presented on stage that start with the letter S. Here’s Part 1: • SamanTree Medical SA — Olivier Delporte • Sana Health — Richard Hanbury • Scout — Alex Jiao • Sensars — Guy Siman • Sensome — Franz Bozsak • SERDA therapeutics — Gabor Heltovics • ShakeIQ, Inc. — David Feygin, PhD, MBA • Shape Memory Medical Inc. — Edward (Ted) Ruppel • SIMPLEX QUANTUM, Inc. — Erick Voorhees • Sirica Therapeutics — Uli K. Chettipally, MD., MPH. • Skope Inc — David Blossom • Sleep Mechanics — Andrew Goldman • Solaris Endovascular — Randy Hubbell • Solenic Medical Inc. — James Lancaster • SOMAVAC® Medical Solutions, Inc. — Elizabeth Hoff Tune in later today to see part 2 featuring another 15 presenting companies that start with the letter S. PS: Registration is now open for LSI USA ‘26 next March 16-20 in Dana Point, California. Secure your spot early to take advantage of our best rates and have first priority for our hotel room block.

Avobis Bio is developing a solution to address the complexity of healing chronic wounds. Through a combination of implantable, bioabsorbable materials and mesenchymal stem cells, the company aims to treat a variety of different indications. The lead product in development at Avobis is for patients suffering from chronic fistulas related to Crohn's Disease. Want to learn more about Avobis Bio? Catch Tiffany Johnson Brown, PhD’s full video presentation from LSI USA ‘25 on our website and YouTube channel. PS: Registration is now open for LSI USA ‘26 next March 16-20 in Dana Point, California. Secure your spot early to take advantage of our best rates and have first priority for our hotel room block.

Yep. As predicted, this one was fun. At #LSI2025 I had the honor of chairing a panel entitled "Founder does not equal CEO". An important, if not controversial, topic in early stage MedTech. During the session my fellow panel members and I discussed varying perspectives of the founder, board member, investor and incoming CEO. We covered what its like to be the one stepping aside (willingly or not), the board member facing the transition decision, the investor that wants to make a change but may make too late, and lastly from the CEO that takes over. All of this was accented by examples of successful transitions, poorly handled ones and ones that should happen but didn't and how each of how these impacted the companies, the people and the funds involved. Thanks to my fellow panel members Paul LaViolette, Kelly Constable, Todd Usen and Dan Sands for a great session. And a special thanks to the organizers at #LSI2025 for providing a format to discuss topics like this one - sessions like this help grow our MedTech community and advance the cause for the patients we all serve. #medicaldevicesgroup #LSI2025 #LSIUSA

Continuing our ABCs of LSI USA ‘25 — today we’re featuring the emerging Medtech and Healthtech companies who presented on stage that start with the letter R. • Radialis — Michael Waterston • RADuxtion Inc — Phillip Kingma • Reach Neuro — Marc Powell • Reach Orthopaedics — Christina Goudy • Reborn Medical — Shir Kashi • Rekovar — Shiva Sharareh, PhD • Reprieve Cardiovascular, Inc. — Mark Pacyna • Reselute — Cambre Kelly • Restera — Rick O'Connor • Resurge Therapeutics — Mikael Trollsas • Retia Medical — Marc Zemel • RetiSpec — Eliav Shaked 🇮🇱 • RevBio, Inc — Brian Hess • RevealDx — Chris Wood • Rivanna Medical, Inc — Will Mauldin • ROB'E — Jury Schewel, PD Dr. med. • Roivios, Ltd — John Erbey • Runway Healthcare — Jeffrey O'Donnell, Jr. • Rx Bandz — Jessica Walsh Tune in each day as we recap LSI USA ‘25 from A to Z. PS: Registration is now open for LSI USA ‘26 next March 16-20 in Dana Point, California. Secure your spot early to take advantage of our best rates and have first priority for our hotel room block.

Berlin Heals Holding AG is on a mission to revolutionize the treatment of heart failure with its breakthrough Cardiac Microcurrent Therapy Device, C-MIC, offering vital new hope for patients battling chronic heart conditions. C-MIC is a small implantable device that propagates reverse remodeling of the cardiac muscle tissue by delivering a constant but minimal electrical direct current equivalent to physiological microcurrents. The C-MIC transmits the electrical currents through two leads: one positioned on the epicardium of the left ventricle and the other within the right ventricular cavity. One of the most notable aspects of the company’s technology is the potential for sustained benefit, even after the device is turned off. The device is a near-curative treatment for patients with heart failure that propagates the reverse remodeling of cardiac muscle tissue to restore heart function and size, thereby reducing the symptoms of heart failure and improving quality of life. Want to learn more about Berlin Heals? Catch John Brumfield’s full video presentation from LSI USA ‘25 on our website and YouTube channel. PS: Registration is now open for LSI USA ‘26 next March 16-20 in Dana Point, California. Secure your spot early to take advantage of our best rates and have first priority for our hotel room block.

Continuing our ABCs of LSI USA ‘25 — today’s letter of the day is Q for Qureator . Qureator, CEO Kyu Baek presented last month at LSI USA ‘25. The company is a pioneering AI-powered human biology platform company dedicated to revolutionizing drug discovery and development for complex diseases. Traditional drug discovery models such as AI-driven computational predictions, animal testing, and 2D cell cultures struggle to replicate human biology accurately, leading to high failure rates and costly inefficiencies. Qureator bridges this gap by integrating Next-Generation Microphysiological Systems (MPS) technology with cutting-edge AI-driven solutions, offering a human biology-based platform that mimics complex disease phenotypes and patient-specific responses. The full video presentation will be uploaded to our website and YouTube channel in the coming weeks, so stay tuned to learn more about Qureator. PS: Registration is now open for LSI USA ‘26 next March 16-20 in Dana Point, California. Secure your spot early to take advantage of our best rates and have first priority for our hotel room block.